Asacol 3rd-Party Payors Want Another Shot At Class Cert.
Buyers of Allergan's ulcerative colitis drug Asacol asked a Massachusetts federal court Friday for permission to renew their class certification bid after a trip to the First Circuit in their suit...To view the full article, register now.
Already a subscriber? Click here to view full article